Drug factory · FDA FEI 2000012832
PharmaEssentia Corporation, Taichung Plant
3F, No. 28, Keya West Rd., Daya Dist, , Taichung, Taiwan
No problems found at FDA's last inspection, Jul 28, 2026.
No Action Indicated: inspectors found no objectionable conditions.
2 drug inspections on record since 2023: 1 with no problems, 1 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Ropeginterferon Alfa-2b | Makes the active ingredient and tests it | PharmaEssentia USA | 73536-500 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Jul 28, 2026 | No problems found | Drug Quality Assurance | — |
| Apr 18, 2023 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
Registered with FDA for: analysis; api manufacture; manufacture.